Abstract-Heptaminol
AMP amidate (HAA), a newly developed nucleotide deriva tive, was found to restore the immunosuppression in mice due to the induction of suppressor T (Ts) cells by concanavalin A (Con A) (50 ag/body).
HAA also inhibited Con A-mediated in vitro induction of Ts cells. On the contrary, the administration of HAA in mice primed with keyhole lympet hemocyanin (KLH) (30 iig/body) caused an enhanced induction of antigen specific helper T (Th) cells. Effects of HAA on Ts and Th cells were found to be dependent on their level of induction. The administration of HAA also increased the spleen cell number and augmented the plaque forming cell response to some extent in cyclophosphamide treated mice. The present results suggested that HAA-mediated immunopoten tiation was possible by a combined suppressive effect on Ts cells and enhancing effect on Th cells.
A new nucleotide derivative, heptaminol AMP amidate (HAA), N-(1,5-dimethyl-5 hydroxy)hexyladenosine-5'-phosphorami date, was prepared from 5'-AMP and hep taminol, following the method of Chambers and Moffatt (1) . It was reported that HAA potentiated the primary humoral immune response in both normal mice and immuno suppressive spontaneously hypertensive rats (SH R) due to declined T cell functions (2) .
Furthermore, it was also found that HAA potentiated the in vitro primary humoral im munity enumerated by the plaque forming cell (PFC) response when T cell-dependent (TD) antigen sheep red blood cell (SRBC) sensitized spleen cells were pulsed with HAA during the early phase of cell culture (3). On the other hand, such an early pulse with HAA was not found to be effective against T cell independent (TI) antigens. The previous in vivo and in vitro results clearly indicated the possibility that HAA might mediate its func tion through T cells. In order to understand the mechanism of HAA-mediated immuno potentiation, the present study was under taken to elucidate the effect of HAA on T cell subpopulations, namely suppressor T (Ts) and helper T (Th) cells.
In this study, concanavalin A (Con A) and keyhole lympet hemocyanin (KLH) were used to induce Ts and Th cells, respectively. The effect of HAA on cyclophosphamide (CY) mediated immunosuppression was also ex amined.
Materials and Methods
Animals: Male BALB/c mice (Charles River Inc., Japan), 8-10 weeks of age, were used in the experiments. The mice were housed under a 12-hr light and dark cycle.
Materials: HAA was kindly given to us by Yamasa Shoyu Co., Ltd. (Japan) . Other materials were purchased from the following sources: SRBC (Nihon Bio-Material Center Co., Japan), Con A (Seikagaku Kogyo Co., Ltd., Japan), Eagle's minimum essential medium (MEM) and RPMI 1640 medium (Nissui Pharmaceutical, Japan), agar and fetal bovine serum (FBS, Lot No. 30051) (Gibco), dextran (Pharmacia), trinitrobenzene sulfonic acid and glycylglycine (Wako Pure Chemical, Japan), CY, 2-mercaptoethanol (2-ME), trypan blue and a-methyl-D-man noside (Nakarai Chemicals, Japan).
Assay of antibody responses in vivo and in vitro: Mice were immunized with SRBC (1 X108) by intravenous injection. After 4 days of immunization, mice were sacrificed and splenocytes were examined for the number of anti-SRBC IgM plaque forming cells (PFC) by hemolytic plaque according to the method of Jerne and Nordin (4) .
Following the method of Mishell and Dutton (5), BALB/c mice spleen cells (0.5 1 X107) were cultured with 2 x 106 SRBC or 1.0 /ag/ml trinitrophenylated (TNP)-KLH in 2 ml of RPMI 1640 medium supplemented with 10% FBS and 1 x10-5 M 2-ME at 37°C for 4 days under 5% CO2 and 95% air. All cultures were carried out in 24-well, multidish culture plates (Nunc, Denmark). In vitro humoral immune response was determined by IgM PFC assay. The indicator SRBC for the TNP-KLH response were lightly coupled with trinitrophenyl following the method of Rit tenberg and Pratt (6) .
In vivo induction of Ts cells by Con A: According to the procedure of Rich and Pierce, Ts cells were induced by the in travenous injection of Con A at the dose of 50 ,ug and 100 ag/body to BALB/c mice, 24 hr before immunization with SRBC (7). HAA (10 mg/kg) was administered orally for 5 consecutive days from the day of Con A in jection. Activity of Ts cells was enumerated by their suppressive effect on the anti-SRBC response, which was determined after 4 days of immunization.
Generation of Con A-induced Ts cells in vitro: To generate the nonspecific Ts cells in vitro by Con A, spleen cells (5x106) from BALB/c mice were precultured for 48 hr with Con A (10 fig/ml) in 2 ml of RPMI 1640 medium supplemented with 10% FBS at 37'C in a humidified atmosphere of 5%C02 and 95% air, according to the method of Rich and Pierce (7). Cells were also precultured with out Con A under the same condition to verify the generation of Ts cells. Precultures with Con A were done in the presence and absence of HAA (5 x 10-4 M). These cells were po oled and washed once with MEM containing 20 mg/ml of a-methyl-D-mannoside and twice with only MEM, and then the cells were resuspended in culture medium. These cells were added in different concentrations (0.5 2 x 105) to normal spleen cell cultures of 4 days duration using SRBC as the antigen. Activity of Ts cells was enumerated by their effects on the anti-SRBC PFC response of the normal culture.
CY-induced immunosuppression: CY was injected to BALB/c mice at the dose of 40 mg/kg, i.p., for 2 days before immunization with SRBC. The anti-SRBC PFC response was measured after 4 days of immunization. Mice were treated daily with HAA at a dose of 10 mg/kg, p.o., from the day of immunization.
In vivo induction of antigen specific Th cells: To induce KLH specific Th cells, BALB/ c mice were injected with KLH (30-100 ,ug/ body, i.p.) absorbed on 4 mg aluminium hy droxide gel (alum), following the method of Okimura et al. (8) . The test groups were treated with HAA (10 mg/kg, p.o.) for 4 consecutive days. Then the mice were sacri ficed, and the pooled spleen cells were cultured (1 x107 cells/well) with TNP-KLH (1 ,ug/ml) for four days. The activity of KLH specific Th cells was determined by anti-TNP PFC assay. TNP-KLH was prepared by the method of Rittenberg (9).
Statistical analysis: The statistical analyses of the data from the in vivo experiments were performed by Student's t-test.
Results
Effects of HAA on Con A-induced im munosuppression in vivo: As depicted in Fig.  1 , the immune response in mice treated with a single injection of Con A at the dose of 50 and 100 ,ag/body, i.p., was significantly inhi bited by 49% and 86%, respectively. Oral administration of HAA to mice pretreated with 50 ag Con A significantly enhanced the anti SRBC PFC/spleen response to 141%, when compared with the 50 ug Con A-injected group. HAA administration to 100 ag Con A injected mice could not cause such an effect on the PFC response.
Effects of HAA on the in vitro generation of Ts cells: As shown in Fig. 2 , when spleen cells were precultured for 48 hr without Con A and then were added in three different concen trations to normal cultures, there was no substantial change in the anti-SRBC PFC response. On the other hand, addition of Con A-educated cells to normal cultures caused inhibition of the in vitro humoral immune re sponse in a dose-dependent manner. The anti-SRBC PFC response declined to 84, 64 and 59% of that in the normal culture, re spectively, for the addition of 5 x 104, 1 x 105 and 2 X105 Con A-educated cells. The ob served suppression of immune response proved that Ts cells were generated in the cultures with Con A. On the contrary, when Con A+HAA-educated cells were added to normal cultures, there was no inhibition of immune response. Addition of 5x104' 1 x105 and 2 x 105 Con A+HAA-educated cells to the cultures caused, respectively, 121, 183 and 219% higher PFC responses than those found for the addition of corresponding con centrations of Con A-educated cells to the culture. These observations clearly demon strated that Con A-induced proliferation of Ts cells was inhibited by HAA. Effects of HAA on the in vivo induction of Th cells: As illustrated in expt. 1 of Fig. 3 , in vitro activity of KLH-induced Th cells of HAA administered mice is 157% higher than that of the control group (primed with 30 ug KLH/ body). However, as has been shown in the expt. 2 of Fig. 3 , the potentiating effect of HAA was not observed when Th cell in duction was done with a higher dose of KLH (100 ag/body).
Discussion
In the previous in vivo study, it was found that HAA caused the maximum anti-SRBC PFC response in normal mice when adminis tered orally at the dose of 10 mg/kg for 4 consecutive days. In addition, oral adminis tration of HAA at 100 mg/kg for 4 con secutive days caused a declination from the control anti-SRBC PFC response (2). In the same study, it was also noted that chronic administration of HAA to immunosuppressive SHR rats significantly potentiated the immune response. There are many reports that im munosuppression in SHR rats is due to a declined T cell function (10-12). Denian et al.
(13) demonstrated that immunosuppression in SHR rats was restored by thymus grafts or thymus extracts. Therefore, it was appre hended that HAA might augment T cell func tions. This was supported by the findings of in vitro studies that HAA-mediated im munopotentiation was only possible against TD antigen SRBC (3). In the present study, since HAA possessed a biphasic action in vivo and in vitro, we attempted to find the specific effects of an optimal dosage of HAA, 10 mg/ kg in vivo and 5x10-4 M in vitro, on T cell subpopulations.
As was reported by Rich and Pierce (7), higher doses of Con A were used in the present investigation to induce the non specific Ts cells. Induction of nonspecific Ts cells by Con A both in vivo and in vitro was demonstrated in the present study, which was enumerated by their inhibiting effects on the anti-SRBC PFC response. HAA inhibited the induction of Ts cells both in vivo and in vitro. However, at a higher dose of Con A (100 fig/body ), which caused a severe im munosuppression in mice, HAA could not exert any effect.
Furthermore, HAA also potentiated the in vivo induction of antigen-specific Th cells when a sub-optimal dose of antigen KLH (30 fig/body) Moreover, CY-mediated immunosuppres sion was reported to originate from an inhi bition of Th cells (14). In the present study, it was found that in CY injected mice, HAA significantly increased the spleen cell number and restored the immunosuppression to some extent. These data show that HAA has the ability to generate and activate the Th cells along with its inhibiting effects on Ts cells.
Furthermore, in the previous in vitro study, it was revealed that the HAA-mediated im munopotentiation was closely related to an elevated level of cAM P, and the pattern of HAA-mediated effects on PFC response was similar to that of dibutyryl cyclic AMP (3). Katz et al. (15) suggested that potentiation of the PFC response by dibutyryl cAMP or by agents elevating intracellular cAMP level was mediated by a selective suppressive effect on Ts cells, which resulted in a relative increase in the activity of Th cells.
Moreover, it may be worth mentioning here that an elevated level of cAMP triggers the activation of B cells in the early phase of immune response (16). It can be speculated that elevation of cAM P level and specific effects on T cell subpopulations work syn ergistically to make possible the potentiation of humoral immune response by HAA.
Furthermore, since adenosine is present in the structure of HAA, it can also classified as a purine analog. Recently, a number of new purine-related compounds have been re ported to possess active immunopoten tiating activity and to modulate T cell func tions (17). As the present study revealed that HAA is a compound which can modulated the functions of T cell subpopulations spe cifically, like other purine-related compounds, HAA also has potential use as an immuno potentiator to reverse tumor-, virus and chemotherapy-induced immunosuppression.
